Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer
Original Publication Date: June 22, 2014 11:28PM
Publication Updated: January 8, 2025 10:51PM
MONTREAL – Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX). Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company’s shareholders last week.
News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
